Occurrence of Venous Thromboembolism in Patients with Lung Cancer and Its Anticoagulant Therapy
Lung cancer is the first leading cause of morbidity and mortality in the world. Venous thromboembolism (VTE) is a recognized complication in patients with lung cancer, which is one of the leading cause of death in lung cancer patients. The cancer-related, patient-related and treatment-related factor...
Main Authors: | Hui DU, Jun CHEN |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2018-10-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2018.10.09 |
Similar Items
-
Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review
by: Anne Rossel, et al.
Published: (2020-03-01) -
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer
by: Alice Labianca, et al.
Published: (2020-07-01) -
Evolving Treatment Options for Cancer-Related Venous Thromboembolism∗
by: Doaa Attia, MD, et al.
Published: (2020-09-01) -
Evaluation of post-operative venous thromboembolism prophylaxis in lung transplant patients
by: Douglas, Randi M., et al.
Published: (2012) -
Diagnostic and prognostic importance of venous thromboembolism in ovarian cancer
by: Dejan Kupnik, et al.
Published: (2007-03-01)